News | Catheter | February 09, 2024

BIOTRONIK and IMDS Join Forces to Launch Innovative Micro Rx Catheter

Meticulously designed rapid exchange catheter now commercially available in the United States

Meticulously designed rapid exchange catheter now commercially available in the United States

February 9, 2024 — BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily enhance guidewire support during percutaneous coronary interventions (PCI). This cutting-edge device, exclusively distributed by BIOTRONIK, is manufactured by IMDS (Interventional Medical Device Solutions). Micro Rx catheter marks the fourth IMDS product BIOTRONIK has brought to the U.S., creating a compelling portfolio of devices which includes NHancer RxTrapIT, and ReCross catheters.  

Dr. Ashish Pershad, MD, Director of Interventional Cardiology at Chandler Regional Medical Center and Mercy Gilbert Medical Center, one of the first users of the MicroRx catheter, shared his experience. “It provides good support and has a low profile allowing for great tip control for coronary guidewires in complex lesions. Not having to switch out your OTW catheter after you cross a difficult lesion is a huge convenience in an era where 190 cm wires are the norm in most cath labs.” 

Acknowledging the intricacies involved in navigating through challenging vascular anatomies, such as tortuous vessels and highly stenosed lesions, the Micro Rx catheter is designed to prioritize user-friendly intervention, eliminating the need for trapping. This approach aims to mitigate the risk of vascular trauma during procedures, subsequently reducing the overall duration of patients' exposure to the catheterization lab environment and associated risks. It has the potential to enable non-chronic total occlusion (CTO) operators to successfully treat more complex anatomies.3,4

“IMDS has invested its expertise and dedication into the development of the Micro Rx catheter, with a specific focus on alleviating challenges in PCI,” said Ryan Walters, President at BIOTRONIK USA. “This has resulted in a state-of-the-art solution, benefiting both physicians and the patients. We are proud to bring this innovation to the U.S. market.” 

For more information: www.biotronik.com

References:  

1 Profile compared to Finecross MG Coronary Micro-Guide Catheter  

End-stop is 6F Guide Extension Catheter compatible  

3 Goel PK, Sahu AK, Kasturi S, et al. Guiding principles for the clinical use and selection of microcatheters in complex interventions. Front. Cardiovasc. Med. 2022;9:724608 doi: 10.3389/fcvm.2022.724608 

4 Leibundgut, G. et Al. A Novel Device for Additional Guide Wire Support to Cross Tortuous Anatomy and Tight Lesions - The Micro Rx Rapid Exchange Microcatheter. Journal of Invasive Cardiology. 1-9  


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now